MAPT and amyloidosis: Studies of the brains of patients treated with Aβ immunotherapy have shown a decrease of total Aβ burden and a decrease of neurite curvature ratio and a [57-59] and an increase of amyloid deposition in neocortical blood vessels that might decrease over time [59], without any strong effect on tau [57] or α-synuclein [60] clearance.